The complex relationship between magnesium and serum parathyroid hormone: A study In patients with Chronic Intestinal Failure

Magnesium Research

Volumn 22, Issue 1, 2009, Pages 37-43

  Pironi, Loris ^a   Malucelli, Emil ^a   Guidetti, Mariacristina ^a   Lanzoni, Elisabetta ^a   Farruggia, Giovanna ^a   Pinna, Antonio Daniele ^a   Barbiroli, Bruno ^a   Iotti, Stefano ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Istituto Nazionale Biostrutture e Biosistemi   (Italy)

Author keywords

Home parenteral nutrition; Intravenous hydration; Magnetic resonance spectroscopy; Skeletal muscle

Indexed keywords

MAGNESIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; BLOOD; CHRONIC DISEASE; ENTEROPATHY; FEMALE; HUMAN; INTESTINE; MALE; METABOLISM; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARENTERAL NUTRITION; SKELETAL MUSCLE; TRANSPLANTATION;

ADULT; CHRONIC DISEASE; FEMALE; HUMANS; INTESTINAL DISEASES; INTESTINES; MAGNESIUM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MUSCLE, SKELETAL; PARATHYROID HORMONE; PARENTERAL NUTRITION, HOME;

EID: 66149105472     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2009.0158     Document Type: Article

References (49)

1. Takahashi S, Okada K, Yanai M. Magnesium and para- thyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients. Pent Dial Int 1994; 14: 75-8.
2. Pletka P, Bernstein DS, Hampers CL, Merrill JP, Sher- wood LM. Relationship between magnesium and sec- ondary hyperparathyroidism during long-term hemodi- alysis. Metabolism 1974; 23: 619-30.
3. Parsons V, Papapoulos SE, Weston MJ, Tomlinson S, O'Riordan JLH. The long-term effect of lowering dialy- sate magnesium on circulating parathyroid hormone in patients on regular haemodialysis therapy. Acta Endo- crinol 1980; 93: 455-60.
4. Gonella M, Bonaguidi F, Buzzigoli G, Bartolini V, Mar- iani G. On the effect of magnesium on the PTH secre- tion in uremic patients on maintenance hemodialysis. Nephron 1981; 27: 40-2.
5. Massry SG, Coburn JW, Kleeman CR. Evidence for sup- pression of parathyroid gland activity by hypermagnese- mia. J Clin Invest 1970; 49: 1619-29.
6. Alfrey AC, Miller NL, Butkus D. Evaluation of body magnesium stores. J Lab Clin Med 1974; 84: 153-62.
7. Rob PM, Dick K, Bley N, et al. Can one really measure magnesium deficiency using the short-term magnesium loading test? J Intern Med 1999; 246: 373-8.
8. Elin RJ. Assessment of magnesium status. Clin Chem 1987; 33: 311-4.
9. Dynker T, Wester PO. The relation between extra- and intracellular electrolytes in patients with hypokalemia and/or diuretic treatment. Acta Med Scand 1978; 204: 269-82.
10. Rob PM, Bley N, Dick K, Rohwer J, Sack K. Magne- sium deficiency after renal transplantation and cyclo- sporine treatment despite normal serum magnesium concentration detected by a modified magnesium- loading-test. Transplant Proc 1995; 27: 3442-3.
11. Wolf FI. TRPM7: Channeling the future of cellular mag- nesium homeostasis? Sci STKE 2004; 233: pe23.
12. Maguire ME. Magnesium transporters: properties, reg- ulation and structure. Front Biosci 2006; 11: 3149-63.
13. Topala CN, Groenestege WT, Thebault S, et al. Molec- ular determinants of permeation through the cation channel TRPM6. Cell Calcium 2007; 41: 513-23.
14. 2+-homeostasis regulation. Magnes Res 2007; 20: 6-18.
15. 2+ trans- port in the heart. Nature 1990; 346: 841-4.
16. 2+ during meta- bolic stimulation of rat cardiac myocytes and perfused hearts. Arch Biochem Biophys. 2000; 374: 395-401.
17. Murphy E. Mysteries of Magnesium Homeostasis. Circ Res 2000; 86: 245-8.
18. 2+ contents in erythro- cytes: a simple but still undisclosed cell model. Magnes Res 2007; 20: 161-7.
19. Altura BM, Altura BT. Magnesium ions contraction of vascular smooth muscles: relationship to some vascu- lar disease. Fed Proc 1981; 40: 2672-9.
20. Stephenson EW, Podolsky RJ. Regulations by magne- sium of intracellular calcium movement in skinned muscle fibers. J Gen Physiol 1977; 69: 1-16.
21. 2+] in the human skelet al. muscle in different meta- bolic condition. Magn Reson Imag 2000; 18: 607-14.
22. 31P-MRS. Magnes Res 2008; 21: 157-62.
23. Pironi L, Paganelli F, Labate AM, et al. Safety and effi- cacy of home parenteral nutrition for chronic intesti- nal failure: a 16-year experience at a single centre. Dig Liver Dis 2003; 35: 314-24.
24. Pironi L, Labate AM, Pertkiewicz M, et al. Prevalence of bone disease in patients on home parenteral nutri- tion. Clin Nutr 2002; 21: 289-96.
25. Kayne LH, Lee DBN. Intestinal magnesium absorption. Miner Electrolyte Metab 1993; 19: 210-7.
26. Beier UH, Kaplan B, Setty S, et al. Electrolyte imbal- ances in pediatric living related small bowel transplan- tation. Transplantation 2008; 85: 217-23.
27. Pironi L, Guidetti M, Lauro A, et al. Bone mineral den- sity and bone turnover after successful intestinal trans- plant in adult recipients: a preliminary report. Nutr Ther Metabol 2008; 26: 184-9.
28. Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Kilburn J. Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism. Osteoporos Int 2006; 17: 1022-32.
29. Kanazawa I, Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T. A case of magnesium deficiency associated with insufficient parathyroid hormone action and severe osteoporosis. Endocrine J 2007; 54: 935-40.
30. Nakamura K, Ueno K, Nishiwaki T, Saito T, Tsuchiya Y, Yamamoto M. Magnesium intake and bone mineral density in young adult women. Magnes Res 2007; 20: 250-3.
31. Jeejeebhoy KN. Metabolic bone disease and total par- enteral nutrition: a progress report. Am J Clin Nutr 1998; 67: 186-7.
32. Lau K, Bourdeau J. Parathyroid hormone action in cal- cium transport in the distal nephron. Curr Opin Nephrol Hypertens 1995; 4: 55-63.
33. Leicht E, Biro G. Mechanisms of hypocalcaemia in the clinical form of severe magnesium deficit in the human. Magnes Res 1992; 5: 37-44.
34. Millard H, Durlach V, Durlach J. Red blood cell magne- sium concentrations: analytical problems and signifi- cance. Magnes Res 1995; 8: 65-76.
35. MRUI - Magnetic Resonance User Interface http://www.mrui.uab.es/mrui/.
36. Harris RC, Hultman E, Nordesjo LO. Glycogen, glyco- lytic intermediates, and high-energy phosphates deter- mined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest 1974; 33: 109-20.
37. Research Centre for in vivo Molecular Diagnosis (CeR- MiV) http://www.cermiv. unibo.it.
38. Cholst IN, Steinberg SF, Tropper PJ, Fox HE, Segre GV, Bilezikian JP. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310: 1221-5.
39. Body JJ, Cryer PE, Offord KP, Heath III H. Epineph- rine is a hypophosphatemic hormone in man. Physio- logical effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hor- mone, and calcitonin. J Clin Invest 1983; 71: 572-8.
40. Body JJ, Dumon JC, Seray F, Cleeren A. Recovery of Parathyroid Hormone Secretion during Correction of Tumor-Associated Hypercalcaemia. J Clin Endocrinol Metab 1992; 74: 1385-8.
41. Navarro JF, Macía ML, Gallego E, et al. Serum magne- sium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol 1997; 31: 275-80.
42. Navarro JF, Mora C, Jiménez A, Torres A, Macía M, García J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 1999; 34: 43-8.
43. Cho MS, Lee KS, Lee YK, et al. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J Intern Med 2002; 17: 114-21.
44. Garber AJ. Effects of Parathyroid Hormone on Skele- tal Muscle Protein and Amino Acid Metabolism in the Rat. J Clin Invest 1983; 71: 1806-21.
45. Baczynski R, Massry SG, Magott M, el-Belbessi S, Kohan R, Brautbar N. Effect of parathyroid hormone on energy metabolism of skelet al. muscle. Kidney Int 1985; 28: 722-7.
46. Mannstadt M, Juppner H, Gardella TJ. Receptors for PTH and PTHrH: their biological importance and func- tional properties. Am J Physiol 1999; 277: F665-F675.
47. Usdin TB, Bonner TI, Hoare SR. The parathyroid hor- mone 2 (PTH2) receptor. Recept Channels 2002; 8: 211-8.
48. Ritz E, Boland R, Kreusser W. Effects of vitamin D and parathyroid hormone on muscle: potential role in ure- mic myopathy. Am J Clin Nutr 1980; 33: 1522-9.
49. 2+ in human blood after exercise. Life Sci 2005; 77: 1211-25.